Pages:
- A Sitemap for LambLawOffice.com
- About Our Firm
- Alabama: Medical Records Copying Charges Law / Statute
- Alaska: Medical Records Copying Charges Law / Statute
- Archive
- Arizona: Medical Records Copying Charges Law / Statute
- Arkansas: Medical Records Copying Charges Law / Statute
- Asbestos & Mesothelioma Overview
- Asbestos Claims: How Do I Get Legal Compensation?
- Attorney Profile: Thomas J. Lamb
- Benzene Cancer Resources
- Benzene Case Evaluation Form
- Benzene Cases Overview
- Benzene Exposure
- Benzene Exposure and AML
- Benzene Exposure and MDS
- Benzene Exposure in Industries
- Benzene-Containing Products
- Benzene-Related Diseases
- Benzene: Frequently Asked Questions
- Blog
- Breast Implant and Lymphoma: Resources
- Breast Implant and Lymphoma: Summary of Information
- Breast Implants and Lymphoma FAQs: About the Disease
- Breast Implants and Lymphoma FAQs: Prognosis
- Breast Implants and Lymphoma FAQs: Risk Factors
- Breast Implants and Lymphoma FAQs: Symptoms
- Breast Implants and Lymphoma FAQs: Treatment
- Breast Implants and Lymphoma: FDA Information
- Breast Implants and Lymphoma: Frequently Asked Questions
- Breast Implants and Lymphoma: The Disease
- Breast Implants Cancer Case Evaluation Form
- Breast Implants Cases Overview
- California: Medical Records Copying Charges Law / Statute
- Case Evaluation Explanation
- Case Evaluation Menu
- Class Action vs. Individual Lawsuits
- Colorado: Medical Records Copying Charges Law / Statute
- Connecticut: Medical Records Copying Charges Law / Statute
- Contact Us
- Current Drug Injury Litigations
- Delaware: Medical Records Copying Charges Law / Statute
- Directions to Our Office at Lumina Station
- Disclaimer and Copyright Notices
- District of Columbia: Medical Records Copying Charges Law / Statute
- Drug Injury Cases Overview
- ED Drugs (as well as BPH and PAH drugs)
- FDA Safety Alert about Philips Recall of CPAP Machines, BiPAP Devices, and Ventilators
- Florida: Medical Records Copying Charges Law / Statute
- Frequently Asked Questions
- General Case Evaluation Form
- GenX Cancer Case Evaluation Form
- GenX Cancers Overview
- GenX Contamination of Fayetteville Well Water: Who is at Risk?
- GenX Research Sources
- Georgia: Medical Records Copying Charges Law / Statute
- Hawaii: Medical Records Copying Charges Law / Statute
- Heartburn and Acid Reflux Drugs
- Hepatitis C Treatment Drugs – DAAs
- How Payment for Our Legal Services Works
- How to File a Benzene Workers Compensation Claim in NC
- Idaho: Medical Records Copying Charges Law / Statute
- Illinois: Medical Records Copying Charges Law / Statute
- Incretin Mimetic Drugs
- Indiana: Medical Records Copying Charges Law / Statute
- Iowa: Medical Records Copying Charges Law / Statute
- Kansas: Medical Records Copying Charges Law / Statute
- Kentucky: Medical Records Copying Charges Law / Statute
- Lamb Law Blog
- Learn More About How We Work
- Louisiana: Medical Records Copying Charges Law / Statute
- Maine: Medical Records Copying Charges Law / Statute
- Maryland: Medical Records Copying Charges Law / Statute
- Massachusetts: Medical Records Copying Charges Law / Statute
- Medical Records Copying Charges
- Medical Records Costs Update 2020: 21st Century Cures Act Amends “Patient Rates” Aspect of HITECH
- Mesothelioma and Asbestos Lawsuits
- Mesothelioma, Asbestos, and Legal Compensation: Basic Facts
- Michigan: Medical Records Copying Charges Law / Statute
- Minnesota: Medical Records Copying Charges Law / Statute
- Mississippi: Medical Records Copying Charges Law / Statute
- Missouri: Medical Records Copying Charges Law / Statute
- Montana: Medical Records Copying Charges Law / Statute
- NC Workers Compensation Benzene Disease Claims Filing Deadline
- Nebraska: Medical Records Copying Charges Law / Statute
- Nevada: Medical Records Copying Charges Law / Statute
- New Hampshire: Medical Records Copying Charges Law / Statute
- New Jersey: Medical Records Copying Charges Law / Statute
- New Mexico: Medical Records Copying Charges Law / Statute
- New York: Medical Records Copying Charges Law / Statute
- North Carolina: Medical Records Copying Charges Law / Statute
- North Dakota: Medical Records Copying Charges Law / Statute
- Ohio: Medical Records Copying Charges Law / Statute
- Oklahoma: Medical Records Copying Charges Law / Statute
- Oregon: Medical Records Copying Charges Law / Statute
- Our Investigation of Your Case
- Pennsylvania: Medical Records Copying Charges Law / Statute
- Philips Breathing Devices Case Evaluation Form
- Philips Breathing Devices Recall: Patient Injury Cases Overview
- Philips CPAP Machines Recall: FDA Warning Issued in July 2021
- Practice Areas
- Quick Contact Form
- Reporting Adverse Drug Reactions To The FDA MedWatch Program
- Resources: Legal, Medical, and More
- Rhode Island: Medical Records Copying Charges Law / Statute
- September 2017: New GenX Information Soon to be Released
- Sitemap for All Website Pages
- South Carolina: Medical Records Copying Charges Law / Statute
- South Dakota: Medical Records Copying Charges Law / Statute
- Tennessee: Medical Records Copying Charges Law / Statute
- Texas: Medical Records Copying Charges Law / Statute
- Thank You For Allowing Us To Review Your Possible Case
- Thank You for Completing Our Form
- Thomas J. Lamb – Drug Injury, Asbestos Mesothelioma, Benzene Cancers
- Timeline: GenX Contamination of the Cape Fear River
- Timeline: GenX Study Results
- Type 2 Diabetes Drugs (DPP-4 Inhibitors)
- Type 2 Diabetes Drugs (SGLT-2 Inhibitors)
- Utah: Medical Records Copying Charges Law / Statute
- Vermont: Medical Records Copying Charges Law / Statute
- Virginia: Medical Records Copying Charges Law / Statute
- Washington: Medical Records Copying Charges Law / Statute
- We Will Not Pressure or Rush You to Sign Our Contract of Representation
- West Virginia: Medical Records Copying Charges Law / Statute
- What are Mesothelioma, Asbestos Lung Cancer, and Asbestosis?
- What is Asbestos?
- What We Know About GenX
- While We Are Working on Your Case
- Wisconsin: Medical Records Copying Charges Law / Statute
- Workers Who Could Be Exposed to Benzene
- Wyoming: Medical Records Copying Charges Law / Statute
- Your Drug Injury Case Review
Categories:
Authors:
- Legal Assistant (1)
- Thomas Lamb (620)
Monthly:
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
Recent Posts:
- A Case Report of Hypophosphatemia Leading to the Diagnosis of Mesothelioma
- Xalkori Side Effects: Children Suffering Ocular Toxicity and Severe Visual Loss
- Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly
- Ukoniq Death Risk is Reason for Ukoniq Drug Recall Says FDA
- Five PFAS Chemicals Added to List of Regional Screening and Removal Management Levels by the EPA
- J&J, 2-stepping through talc litigation, faces fresh claims it hid workers’ asbestos exposure
- Drug Injury Research: FDA Resources Online Available for Patients
- CDC: Mesothelioma Deaths Up Among Women
- Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report
- Pericardial Mesothelioma Presenting as Constrictive Pericarditis
- Ukoniq Withdrawn From Market Due to Increased Risk of Patient Deaths
- Health Canada Breast Implant Safety Review Shows High Risk of BIA-ALCL with Textured Implants
- Abemaciclib for Previously Treated Patients With p16ink4A-Deficient Mesothelioma
- MS Drugs Ocrevus and Gilenya Linked to Melanoma, Other Skin Cancers
- EPA rule would finally ban asbestos, carcinogen still in use
- Fosamax Lawsuits Dismissed Again by March 2022 Preemption Ruling
- April 2022 FDA Advisory Committee Meeting For Ukoniq Risk of Death
- Early Clinical Activity With CDK4/6 Inhibitor in Pretreated Mesothelioma
- Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
- Beovu Label Change: Novartis Adds Information, Increases Safety Warnings in February 2022
- How People Can Report Adverse Drug Reactions to the FDA MedWatch Program
- An Overview of Benzene Exposure and its Adverse Health Effects
- First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
- Xeljanz, Rinvoq, and Olumiant Safety Review by European Drug Regulator EMA
- Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study
- Possible Ukoniq Drug Recall Due to Increased Risk of Death
- Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
- Xeljanz Safety Study Final Findings Presented in January 2022
- Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
- Asbestos Exposure and Malignant Mesothelioma in Construction Workers
- Beovu Drug Label Revised December 2021 Was Issued in Europe, But Not in the US
- Xeljanz Safety Alert for People Who Are (1) Older, (2) Current / Past Smokers, or (3) With Cardiovascular or Cancer Risk Factors
- EPA to Require Chemical Companies to Test Toxicity of Products
- Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma
- Immune Checkpoint Inhibitors Extend Survival for Mesothelioma
- Elmiron-associated Retinopathy and Other Elmiron Eye Problem Side Effects
- Beovu: Rates of Intraocular Inflammation and Retinal Vascular Occlusion
- Nivolumab plus ipilimumab confers sustained OS benefit in malignant pleural mesothelioma
- Cancers, Blood Clots, Heart Problems, and Deaths Associated with Xeljanz, Olumiant, and Rinvoq
- FDA Sets New Regulations for Breast Implant Manufacturers
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Olumiant or Xeljanz: Is One of These JAK Inhibitor Drugs Safer?
- Imfinzi-Chemo Combo Improves Survival for Mesothelioma
- Certain Aerosol Antiperspirants Found to Contain High Levels of Benzene
- Philips Ventilators Recall: What The Company Knew and When, What It Did or Did Not Do, and More FDA Findings Released November 2021
- Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
- Immunotherapy combination maintains OS advantage in malignant pleural mesothelioma
- GenX Contamination May Be More Toxic Than EPA Initially Thought
- Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
- Two Padcev-induced TEN / SJS Cases Where Patient Died From Their Padcev Side Effects
- Adding Atezolizumab to Neoadjuvant Cisplatin-Pemetrexed a Feasible Option in Malignant Pleural Mesothelioma
- Drug Regulator MHRA Imposes More Xeljanz Use Limitations in October 2021
- Nivo/Ipi Combo Now ‘Standard of Care’ in Mesothelioma
- Imbruvica Heart-Related Side Effects and Cardiotoxicity Safety Issues
- Access to care varies greatly among patients with malignant pleural mesothelioma
- Possible New Xeljanz Side Effect: Peripheral Neuropathy
- More Data in Support of Surgery for Malignant Pleural Mesothelioma
- Appeals court reinstates suit by Solano County woman against Johnson & Johnson over baby powder
- Padcev Linked to SJS and TEN: From No Warning to “Black Box” in Less Than 2 Years
- Understanding the new therapeutic options for mesothelioma
- Benzene Linked to Non-Hodgkin Lymphoma According to New Review of Past Studies
- Elmiron and Maculopathy: Two Recent Medical Articles About an Elmiron Vision Side Effect
- Xeljanz: Heart Attacks, Strokes, Cancers, Blood Clots, and Deaths – Updated FDA Warnings 2021
- Surgery After Radiotherapy May Improve Outcomes in Patients with Malignant Pleural Mesothelioma
- Tongue: the unusual site in malignant pleural mesothelioma
- Tasigna Drug Injury Lawsuits Federal Court MDL Consolidation Order
- Court upholds award to family of worker who died of asbestos exposure
- Some Research Resources for Drug Safety and Warnings Information
- Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma
- Drug Injury Lawsuits: List of Some Cases Filed in First Half of 2021
- Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma.
- Johnson & Johnson Recalls Neutrogena and Aveeno Sunscreen Over Benzene Contamination Concerns
- Drug Combo Promising in Rare Mesothelioma
- SGLT2 Inhibitors Invokana, Farxiga, Jardiance Linked to Retinal Vein Occlusion
- A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion
- FDA Advisory Committee Meeting Could Review Risk/Benefit Profiles for All JAK Inhibitors
- Osteopontin, GLUT1 and Ki-67 expression in malignant peritoneal mesothelioma: prognostic implications
- The association between pleural fluid exposure and survival in pleural mesothelioma
- EPA Petitioned to Reconsider Requiring Chemours to Fund PFAS Testing
- Philips Bi-Level PAP, CPAP, and Mechanical Ventilators Part of Products Recall in June 2021
- Are Benzene Contaminated Sunscreens Safe to Use?
- Tasigna Lawsuits Update: New Jersey MCL and Federal Court MDL Consolidations
- Vinorelbine extends PFS in relapsed malignant pleural mesothelioma
- Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis
- Novartis Stops 3 Beovu Clinical Trials in May 2021, Wants a Beovu Label Change
- Ocaliva-related Liver Injury Warnings Will be Added to Ocaliva Drug Label
- Health groups sue to make EPA evaluate ‘legacy’ asbestos risk
- A 2021 Look at the Increased Risk of Elmiron-associated Pigmentary Maculopathy
- Why Asbestos Still Threatens Construction Workers’ Health
- Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions
- Guidelines for Diagnosing and Managing Patients with Drug-induced Liver Injury
- Nivolumab prolongs PFS, OS in relapsed malignant mesothelioma
- Ocrevus PML Case Report: Patient Used Ocrevus, Only, Without Prior Tysabri or Gilenya Use
- Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma
- BIA-ALCL Current Recommendations and Potential Future FDA Guidance Changes
- Possible FDA Advisory Committee Meeting for Xeljanz, Olumiant, and Rinvoq in Future
- Incidence of mesothelioma and asbestosis by occupation in a diverse workforce
- There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020
- Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
- Anti-Mesothelin CAR T cell therapy for malignant mesothelioma